Literature DB >> 26905940

Neuropsychological assessment in different King's clinical stages of amyotrophic lateral sclerosis.

Francesca Trojsi1, Gabriella Santangelo2, Giuseppina Caiazzo1, Mattia Siciliano2, Teresa Ferrantino1, Giovanni Piccirillo1, Cinzia Femiano1, Viviana Cristillo1, Maria Rosaria Monsurrò1, Fabrizio Esposito3, Gioacchino Tedeschi1.   

Abstract

Emerging evidence shows that cognitive deficits associated with frontal lobe dysfunction occur from early stages of amyotrophic lateral sclerosis (ALS). We aimed to assess neuropsychological functioning at different stages of ALS to further delineate the occurrence of cognitive impairment alongside the trajectory of ALS as defined by standard assessment procedures. We investigated several cognitive domains in 74 ALS patients classified into four different clinical stages of disease, according to a recently validated staging system for ALS (known as 'King's' system), and evaluated and compared the corresponding cognitive profiles. We found that data derived from global cognitive assessment and several executive (i.e. Frontal Assessment Battery and Trail Making Test B-A) and long-term memory (i.e. memory prose) tests were significantly different among the subsets of ALS patients, showing poorer performances with increasing clinical disability. In conclusion, our preliminary results support the notion that mainly frontotemporal abilities may be impaired during the ALS course and suggest that neuropsychological information could supplement the current clinical staging of patients. However, ALS-specific multi-domain screening instruments, which allow to correct neuropsychological scores for physical disability, should be validated in larger populations worldwide and routinely introduced in clinical practice.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; clinical staging; cognitive impairment; neuropsychological assessment

Mesh:

Year:  2016        PMID: 26905940     DOI: 10.3109/21678421.2016.1143513

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  4 in total

1.  Cognitive impairment across ALS clinical stages in a population-based cohort.

Authors:  Adriano Chiò; Cristina Moglia; Antonio Canosa; Umberto Manera; Rosario Vasta; Maura Brunetti; Marco Barberis; Lucia Corrado; Sandra D'Alfonso; Enrica Bersano; Maria Francesca Sarnelli; Valentina Solara; Jean Pierre Zucchetti; Laura Peotta; Barbara Iazzolino; Letizia Mazzini; Gabriele Mora; Andrea Calvo
Journal:  Neurology       Date:  2019-08-13       Impact factor: 9.910

2.  Intuitive Staging Correlates With King's Clinical Stage.

Authors:  Ahmad Al Khleifat; Rubika Balendra; Ton Fang; Ammar Al-Chalabi
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2021-04-06       Impact factor: 4.092

3.  Screening for Cognitive Function in Complete Immobility Using Brain-Machine Interfaces: A Proof of Principle Study.

Authors:  Dorothée Lulé; Katharina Hörner; Cynthia Vazquez; Helena Aho-Özhan; Jürgen Keller; Martin Gorges; Ingo Uttner; Albert C Ludolph
Journal:  Front Neurosci       Date:  2018-08-15       Impact factor: 4.677

4.  A standard operating procedure for King's ALS clinical staging.

Authors:  Rubika Balendra; Ahmad Al Khleifat; Ton Fang; Ammar Al-Chalabi
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-02-18       Impact factor: 4.092

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.